XML 16 R47.htm IDEA: XBRL DOCUMENT v3.20.1
Collaborative Research, Development and License Agreements - Additional Information (Detail)
$ in Thousands
1 Months Ended 3 Months Ended
Feb. 29, 2020
USD ($)
Feb. 28, 2019
USD ($)
Feb. 28, 2018
USD ($)
Installment
Mar. 31, 2020
USD ($)
Mar. 31, 2019
USD ($)
Dec. 31, 2019
USD ($)
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]            
Revenue recognized       $ 10,919 $ 5,773  
Intangible assets, net       202   $ 2,500
Serum Institute of India Pvt. Ltd. | Collaboration Revenue            
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]            
Revenue recognized       400 $ 100  
Merck, Sharp & Dohme Corp. | Sublicense Agreement            
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]            
Aggregate amount payable to acquire intangible assets     $ 21,000      
Number of installments | Installment     3      
Payment upon obligation $ 7,000 $ 7,000 $ 7,000      
Agreement expiration month and year     2020-04      
Intangible assets, net       $ 200   $ 2,500